The Zhejiang Provincial Engineering Research Center for Organelles Precision Diagnostics and Therapy was approved for establishment by the Zhejiang Provincial Development and Reform Commission in 2024. Led by Eastern Institute of Technology, Ningbo, with Academician Dayong Jin serving as director, the center was jointly established with Ningbo No.2 Hospital and two publicly traded companies: Medicalsystem Biotechnology and Yongxin Optics.
The Engineering Research Center currently has a staff of 65, comprising a high-level talent team that includes one foreign member of the Chinese Academy of Engineering, one member of the Australian Academy of Technology and Engineering, two members of the Canadian Academy of Engineering, nine national-level talents, three Zhejiang Province “KP” talents, and two Ningbo City “DJ” talents.
Focusing on three major research directions—digitalization of organelle interactions, in vitro diagnosis of exosomes, and precision delivery of micro- and nano-drugs—the Center is advancing the research and industrialization of precision medicine in China.




